Prof. Suresh Senan is a radiation oncologist at the Amsterdam University Medical Centers in The Netherlands. He graduated from the National University of Singapore and trained there in internal medicine before moving to the Beatson Oncology Center in Glasgow for his training in clinical oncology.

His research work has focused on stereotactic radiotherapy, treatment of oligometastases, MR-guided adaptive radiotherapy and combined use of systemic agents with lung radiotherapy. He is a faculty member for Chest Tumors at the European Society for Medical Oncology, and faculty of the ESTRO Image-guided SBRT course. He is active in the International Association for the Study of Lung Cancer (IASLC), ASCO and ASTRO. Professor Senan is the recipient of awards from Dutch lung cancer patients (2005), the Heine H. Hansen Award by ESMO and IASLC (2016) and the IASLC James D. Cox Lectureship Award for Radiation Oncology (2025).

Prof. Mischa Hoogeman is Head of Medical Physics at HollandPTC and of the Department of Radiotherapy at Erasmus MC. He is also the Chair of Research & Education at HollandPTC. Since 2017 he has been appointed professor of High-Precision and Adaptive Radiotherapy at Erasmus University Rotterdam, and since 2019 he holds a similar position at Delft University of Technology. In 2020, he was appointed Medical Delta Professor. The overarching goal of his research is to broaden the therapeutic window through the development, implementation and evaluation of high-precision adaptive radiotherapy techniques. Research is being conducted in photon and proton radiotherapy. With respect to proton therapy, his interests lie in probabilistic treatment planning, online adaptive proton therapy, and ultra-high dose rate proton therapy for FLASH. For photon therapy, his interests lie in high-precision and (online) adaptive stereotactic treatments.

Prof. Mischa Hoogeman studied experimental physics at the University of Amsterdam. He continued his education as Ph.D. student at the Institute for Atomic and Molecular Physics (Amolf) studying atomic-scale dynamics of crystalline surfaces with variable-temperature scanning tunnelling microscopy. He obtained his Ph.D. in 1998 at Leiden University. After a Postdoc at the NKI-AVL, Prof. Mischa Hoogeman received his Medical Physics training at the NKI-AVL and Erasmus MC.

Prof. Chiang graduated from the Chinese University of Hong Kong. He has received post-fellow training in stereotactic body radiotherapy in John Hopkins Hospital and Princess Margaret Hospital. He is currently the Assistant Dean of LKS Faculty of Medicine and the Clinical Associate Professor in the Department of Clinical Oncology, the Centre of Cancer Medicine, the University of Hong Kong.

Prof. Chiang is specialized in treating liver and pancreatic cancer. He is renowned in pioneering the combined SBRT and immunotherapy and a novel combination called START-FIT in treating hepatocellular carcinoma. He published over 80 peer-review journals including Lancet Gastroenterology and Hepatology, Jama Oncology, Journal of Clinical Oncology, Gut, Lancet Regional Health Western Pacific, Liver Cancer, and JAMA Network Open. Prof. Chiang is currently the president of Hong Kong Stereotactic Body Radiotherapy Study Group and Principal of Training Centre of Radiotherapy and Oncology, Gleneagles Hospital HK.

Dr. Chua a Clinician-Scientist at the National Cancer Centre Singapore (NCCS) and the Duke-NUS Medical School. He is the Head of Department and Senior Consultant for the Department of Head and Neck and Thoracic Radiation Oncology, Principal Investigator of the Precision Radiotherapeutics and Oncology Programme (PROP) ; and Director of the Data and Computational Science Hub at NCCS. He is currently Associate Professor of Duke-NUS Medical School, Singapore; and Visiting Professor of the Zhongnan Hospital of Wuhan University, China. His work is supported by several National grants including: (1) the NMRC CSA (Investigator-category); (2) the National Research Foundation Competitive Research Programme (NRF-CRP); (3) the Ministry of Education Tier 3 Grant; (4) the NMRC Open Fund Large Collaborative Grant (OF-LCG); and (5) the NMRC Centre Grant, as well as large philanthropic donations, notably from the Goh Foundation to Proton Therapy Research, the Tibore Foundation to the Kua Hong Pak Head and Neck Cancer Research Programme, and the Singapore Rubber Miller Association to the Cancer and Data Science Programme. His key research focus areas are: (1) Developing a comprehensive nasopharyngeal carcinoma clinical and translational research programme that leverages on innovative designs of phase 2-3 trials, a multi-dimensional, deeply-annotated clinical-molecular database, coupled with broad-scale computational genomics approaches for biomarker discoveries; and (2) A translational radiation research programme that leverages on bench-to-bedside expertise to understand the mechanistic pathways of radiation resistance, and to develop new treatment regimens to target these molecular vulnerabilities.

Ms. Kim JiYeun is an Application Specialist at RaySearch Laboratories, focusing on the clinical implementation of oncology information systems and workflow optimization in radiation oncology. She works with hospitals and clinical teams to support the integration and management of comprehensive clinical workflows and improve information management in radiotherapy departments.

She is currently a PhD candidate in Medical Physics at The Catholic University of Korea. Her research focuses on the analysis of oncology information system workflows and the development of structured protocols to support quality management in radiotherapy departments. Her professional interests include oncology information systems and innovation in clinical radiotherapy workflows.

Dr. Sharon Ho completed her medical education at the University of Hong Kong in 2021. She is currently a resident trainee in Clinical Oncology at Pamela Youde Nethersole Eastern Hospital and is undergoing specialist training for Fellowship of the Royal College of Radiologists and Fellowship of the Hong Kong College of Radiologists. She looks forward to further developing her interests in oncology particularly in thoracic cancers as well as in advanced radiotherapy techniques.